Germany has cracked down on the bribery of foreign public officials in recent years, prosecuting and sanctioning nearly 70 individuals and 6 companies to date. But it should do even more to prosecute companies and should apply tougher sanctions.
This report reviews policies in OECD countries. It studies selected eco-innovations (e.g. carbon capture and storage, electric vehicles and fuel cells) and explains why policies differ in Canada, France, or Germany.
English, , 1,221kb
'PISA in Focus' N°3 looks at 15-year-olds' participation in after-school classes and examines its possible impact on their performance.
English, PDF, 443kb
Agricultural research fellowship award grants and international conferences sponsorships of the Co-operative Research Programme (CRP): Biological Resource Management for Sustainable Agricultural Systems; advice for applicants for funding.
This working paper reviews 10 in–depth case studies of urban projects proposed and operating within the realm of Joint Implementation (JI) and the Clean Development Mechanism (CDM) of the Kyoto Protocol. Environment Working Paper No. 29.
Public finances are under pressure around the world. We asked finance ministers from a range of countries: “What actions is your government taking to bolster public finances, while upholding growth and services?”
The unique OECD peer review process has helped improve public policy. It assesses how countries manage the design, adoption and enforcement of regulations according to a conceptual framework. It ensures comparability while taking account of institutional and cultural differences across countries.
Germany embarks on reform of its development co-operation and aims to improve the quality and increase the quantity of its aid.
Germany has been one of the world’s largest bilateral donors for the past two decades, but it spent only 0.35% of its national income on official development assistance (ODA) in 2009.
For many of today’s new biomedical innovations, the distinctions between different forms of medical products such as drugs, diagnostics and devices no longer apply. Biomedicine also tends to realize its potential today through process innovation, even more than product innovation.